Gene · 3020
Papers2,385
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,385
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Methylation Analysis Reveals Epigenetic Congruence Between Bone Sarcomas With H3-3A Mutations and Malignant Giant Cell Tumors of Bone. | Mod Pathol | 2025 | 40157506 | PubTator, text mining | PubMed |
| Role of H3F3A (H3G34W) antibody in the diagnosis of giant cell tumour of bone in the paediatric age group. | Pathol Res Pract | 2025 | 40107010 | PubTator, text mining | PubMed |
| Malignant Giant Cell Tumor of Bone: A Clinicopathologic Series of 28 Cases Highlighting Genetic Differences Compared With Conventional, Atypical, and Metastasizing Conventional Tumors. | Am J Surg Pathol | 2025 | 40077813 | PubTator, text mining | PubMed |
| Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomas. | J Neurooncol | 2025 | 39961939 | PubTator, text mining | PubMed |
| Update on the nature of central giant cell granuloma of the jaw with a focus on the aggressive subtype. | Pathology | 2025 | 39952878 | PubTator, text mining | PubMed |
| [Liquid biopsy for detection of H3K27m and BRAF V600E mutations in patients with diffuse brainstem tumors]. | Zh Vopr Neirokhir Im N N Burdenko | 2025 | 39907662 | PubTator, text mining | PubMed |
| A Rare Pediatric Giant Cell Tumor of the Clivus Bone, H3.3 p.Gly35Trp-mutated: Case Report and Mini-review of the Literature. | Turk Arch Pediatr | 2025 | 39804135 | PubTator, text mining | PubMed |
| Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal Fluid. | Pediatr Blood Cancer | 2025 | 39789738 | PubTator, text mining | PubMed |
| Keratin Positive Giant Cell Rich Tumor of the Pelvic Bone with a HMGA2::NCOR2 Fusion: A Case Report. | Int J Surg Pathol | 2025 | 39773226 | PubTator, text mining | PubMed |
| Investigating glioma genetics through perfusion MRI: rCBV and rCBF as predictive biomarkers. | Magn Reson Imaging | 2025 | 39740747 | PubTator, text mining | PubMed |
| Age-related genomic alterations and chemotherapy sensitivity in osteosarcoma: insights from cancer genome profiling analyses. | Int J Clin Oncol | 2025 | 39688743 | PubTator, text mining | PubMed |
| Genetics of urinary bladder paragangliomas: a multi-center study of a Chinese cohort. | J Endocrinol Invest | 2025 | 39636472 | PubTator, text mining | PubMed |
| MYB::QKI fusion-positive diffuse glioma of the cerebellum: A case report. | Neuropathology | 2025 | 39569742 | PubTator, text mining | PubMed |
| Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection-Update 1. | Neuro Oncol | 2025 | 39387386 | PubTator, text mining | PubMed |
| H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric Gliomas. | bioRxiv | 2025 | 37398299 | PubTator, text mining | PubMed |
| Case report: A rare case of chondrosarcoma-like malignant giant cell tumor in adolescent rib: diagnostic challenges and treatment. | Front Oncol | 2024 | 39882444 | PubTator, text mining | PubMed |
| Significance of Biogenetic Markers in Giant Cell Tumor Differentiation and Prognosis: A Narrative Review. | Diagnostics (Basel) | 2024 | 39795567 | PubTator, text mining | PubMed |
| Genetic alteration analysis of non-pediatric diffuse midline glioma, H3 K27-altered. | Hum Pathol | 2024 | 39701425 | PubTator, text mining | PubMed |
| [Diagnostic challenges of pediatric gliomas; the role of molecular profiling in everyday diagnostics]. | Magy Onkol | 2024 | 39657041 | PubTator, text mining | PubMed |
| Neonatal myoclonus in Bryant-Li-Bhoj syndrome associated with a novel H3F3A variant. | Hum Genome Var | 2024 | 39627236 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3020/papers?page=6